Biohaven Ltd
(NYSE:BHVN)
$18.05
-0.51[-2.75%]
At close: Feb 8
$18.09
0.0400[0.22%]
After Hours: 4:01PM EDT
Day Range17.950 - 18.67052 Wk Range7.100 - 152.560Open / Close18.460 / 18.090Float / Outstanding64.756M / 68.161M
Vol / Avg.687.568K / 1.087MMkt Cap1.230BP/E-50d Avg. Price16.230
Div / Yield (Forward)- / -%Payout Ratio-Total Float64.756MEPS-11.754

Biohaven Stock (NYSE:BHVN), Quotes and News Summary

Biohaven Stock (NYSE: BHVN) stock price, news, charts, stock research, profile.

Loading...
Day Range17.950 - 18.67052 Wk Range7.100 - 152.560Open / Close18.460 / 18.090Float / Outstanding64.756M / 68.161M
Vol / Avg.687.568K / 1.087MMkt Cap1.230BP/E-50d Avg. Price16.230
Div / Yield (Forward)- / -%Payout Ratio-Total Float64.756MEPS-11.754
InvestorsObserver - Jan 24, 2023, 11:24AM
InvestorsObserver - Dec 13, 2022, 11:34AM
Seeking Alpha - Dec 7, 2022, 1:19PM
Seeking Alpha - Nov 25, 2022, 3:50AM
InvestorsObserver - Nov 21, 2022, 10:08AM
Seeking Alpha - Oct 31, 2022, 1:50AM
TipRanks - Oct 21, 2022, 11:42AM
InvestorsObserver - Oct 21, 2022, 10:14AM
Seeking Alpha - Sep 29, 2022, 8:32AM
Seeking Alpha - Sep 19, 2022, 6:52AM
Seeking Alpha - Aug 22, 2022, 7:29AM
Seeking Alpha - Aug 17, 2022, 6:40AM
Sector: Health Care.Industry: Biotechnology
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on discovering and developing therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, immunology, and disease-related biology, including rare disorders. Its neuroscience portfolio includes a broad pipeline of drug candidates modulating distinct nervous system targets, including Kv7, glutamate receptors, myostatin, and TRP channels. Its products target diseases such as migraine, depression, bipolar, and schizophrenia.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-09
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-24
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Biohaven (BHVN) stock?

A

You can purchase shares of Biohaven (NYSE: BHVN) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Biohaven (BHVN) stock?

A

The latest price target for Biohaven (NYSE: BHVN) was reported by SVB Leerink on Tuesday, January 24, 2023. The analyst firm set a price target for 24.00 expecting BHVN to rise to within 12 months (a possible 32.96% upside). 12 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Biohaven (BHVN)?

A

The stock price for Biohaven (NYSE: BHVN) is $18.05 last updated February 8, 2023 at 8:59 PM UTC.

Q

Does Biohaven (BHVN) pay a dividend?

A

There are no upcoming dividends for Biohaven.

Q

When is Biohaven (NYSE:BHVN) reporting earnings?

A

Biohaven’s Q1 earnings are confirmed for Tuesday, May 9, 2023.

Q

Is Biohaven (BHVN) going to split?

A

There is no upcoming split for Biohaven.

Q

What sector and industry does Biohaven (BHVN) operate in?

A

Biohaven is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

Biohaven Stock (NYSE:BHVN), Quotes and News Summary

Biohaven Stock (NYSE: BHVN) stock price, news, charts, stock research, profile.

Loading...
Day Range17.950 - 18.67052 Wk Range7.100 - 152.560Open / Close18.460 / 18.090Float / Outstanding64.756M / 68.161M
Vol / Avg.687.568K / 1.087MMkt Cap1.230BP/E-50d Avg. Price16.230
Div / Yield (Forward)- / -%Payout Ratio-Total Float64.756MEPS-11.754
InvestorsObserver - Jan 24, 2023, 11:24AM
InvestorsObserver - Dec 13, 2022, 11:34AM
Seeking Alpha - Dec 7, 2022, 1:19PM
Seeking Alpha - Nov 25, 2022, 3:50AM
InvestorsObserver - Nov 21, 2022, 10:08AM
Seeking Alpha - Oct 31, 2022, 1:50AM
TipRanks - Oct 21, 2022, 11:42AM
InvestorsObserver - Oct 21, 2022, 10:14AM
Seeking Alpha - Sep 29, 2022, 8:32AM
Seeking Alpha - Sep 19, 2022, 6:52AM
Seeking Alpha - Aug 22, 2022, 7:29AM
Seeking Alpha - Aug 17, 2022, 6:40AM
Sector: Health Care.Industry: Biotechnology
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on discovering and developing therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, immunology, and disease-related biology, including rare disorders. Its neuroscience portfolio includes a broad pipeline of drug candidates modulating distinct nervous system targets, including Kv7, glutamate receptors, myostatin, and TRP channels. Its products target diseases such as migraine, depression, bipolar, and schizophrenia.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-09
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-24
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Biohaven (BHVN) stock?

A

You can purchase shares of Biohaven (NYSE: BHVN) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Biohaven (BHVN) stock?

A

The latest price target for Biohaven (NYSE: BHVN) was reported by SVB Leerink on Tuesday, January 24, 2023. The analyst firm set a price target for 24.00 expecting BHVN to rise to within 12 months (a possible 32.96% upside). 12 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Biohaven (BHVN)?

A

The stock price for Biohaven (NYSE: BHVN) is $18.05 last updated February 8, 2023 at 8:59 PM UTC.

Q

Does Biohaven (BHVN) pay a dividend?

A

There are no upcoming dividends for Biohaven.

Q

When is Biohaven (NYSE:BHVN) reporting earnings?

A

Biohaven’s Q1 earnings are confirmed for Tuesday, May 9, 2023.

Q

Is Biohaven (BHVN) going to split?

A

There is no upcoming split for Biohaven.

Q

What sector and industry does Biohaven (BHVN) operate in?

A

Biohaven is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

Biohaven Stock (NYSE:BHVN), Quotes and News Summary

Biohaven Stock (NYSE: BHVN) stock price, news, charts, stock research, profile.

Loading...
Day Range17.950 - 18.67052 Wk Range7.100 - 152.560Open / Close18.460 / 18.090Float / Outstanding64.756M / 68.161M
Vol / Avg.687.568K / 1.087MMkt Cap1.230BP/E-50d Avg. Price16.230
Div / Yield (Forward)- / -%Payout Ratio-Total Float64.756MEPS-11.754
InvestorsObserver - Jan 24, 2023, 11:24AM
InvestorsObserver - Dec 13, 2022, 11:34AM
Seeking Alpha - Dec 7, 2022, 1:19PM
Seeking Alpha - Nov 25, 2022, 3:50AM
InvestorsObserver - Nov 21, 2022, 10:08AM
Seeking Alpha - Oct 31, 2022, 1:50AM
TipRanks - Oct 21, 2022, 11:42AM
InvestorsObserver - Oct 21, 2022, 10:14AM
Seeking Alpha - Sep 29, 2022, 8:32AM
Seeking Alpha - Sep 19, 2022, 6:52AM
Seeking Alpha - Aug 22, 2022, 7:29AM
Seeking Alpha - Aug 17, 2022, 6:40AM
Sector: Health Care.Industry: Biotechnology
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on discovering and developing therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, immunology, and disease-related biology, including rare disorders. Its neuroscience portfolio includes a broad pipeline of drug candidates modulating distinct nervous system targets, including Kv7, glutamate receptors, myostatin, and TRP channels. Its products target diseases such as migraine, depression, bipolar, and schizophrenia.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-09
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-24
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Biohaven (BHVN) stock?

A

You can purchase shares of Biohaven (NYSE: BHVN) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Biohaven (BHVN) stock?

A

The latest price target for Biohaven (NYSE: BHVN) was reported by SVB Leerink on Tuesday, January 24, 2023. The analyst firm set a price target for 24.00 expecting BHVN to rise to within 12 months (a possible 32.96% upside). 12 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Biohaven (BHVN)?

A

The stock price for Biohaven (NYSE: BHVN) is $18.05 last updated February 8, 2023 at 8:59 PM UTC.

Q

Does Biohaven (BHVN) pay a dividend?

A

There are no upcoming dividends for Biohaven.

Q

When is Biohaven (NYSE:BHVN) reporting earnings?

A

Biohaven’s Q1 earnings are confirmed for Tuesday, May 9, 2023.

Q

Is Biohaven (BHVN) going to split?

A

There is no upcoming split for Biohaven.

Q

What sector and industry does Biohaven (BHVN) operate in?

A

Biohaven is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

Biohaven Stock (NYSE:BHVN), Quotes and News Summary

Biohaven Stock (NYSE: BHVN) stock price, news, charts, stock research, profile.

Loading...
Day Range17.950 - 18.67052 Wk Range7.100 - 152.560Open / Close18.460 / 18.090Float / Outstanding64.756M / 68.161M
Vol / Avg.687.568K / 1.087MMkt Cap1.230BP/E-50d Avg. Price16.230
Div / Yield (Forward)- / -%Payout Ratio-Total Float64.756MEPS-11.754
InvestorsObserver - Jan 24, 2023, 11:24AM
InvestorsObserver - Dec 13, 2022, 11:34AM
Seeking Alpha - Dec 7, 2022, 1:19PM
Seeking Alpha - Nov 25, 2022, 3:50AM
InvestorsObserver - Nov 21, 2022, 10:08AM
Seeking Alpha - Oct 31, 2022, 1:50AM
TipRanks - Oct 21, 2022, 11:42AM
InvestorsObserver - Oct 21, 2022, 10:14AM
Seeking Alpha - Sep 29, 2022, 8:32AM
Seeking Alpha - Sep 19, 2022, 6:52AM
Seeking Alpha - Aug 22, 2022, 7:29AM
Seeking Alpha - Aug 17, 2022, 6:40AM
Sector: Health Care.Industry: Biotechnology
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on discovering and developing therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, immunology, and disease-related biology, including rare disorders. Its neuroscience portfolio includes a broad pipeline of drug candidates modulating distinct nervous system targets, including Kv7, glutamate receptors, myostatin, and TRP channels. Its products target diseases such as migraine, depression, bipolar, and schizophrenia.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-09
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-24
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Biohaven (BHVN) stock?

A

You can purchase shares of Biohaven (NYSE: BHVN) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Biohaven (BHVN) stock?

A

The latest price target for Biohaven (NYSE: BHVN) was reported by SVB Leerink on Tuesday, January 24, 2023. The analyst firm set a price target for 24.00 expecting BHVN to rise to within 12 months (a possible 32.96% upside). 12 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Biohaven (BHVN)?

A

The stock price for Biohaven (NYSE: BHVN) is $18.05 last updated February 8, 2023 at 8:59 PM UTC.

Q

Does Biohaven (BHVN) pay a dividend?

A

There are no upcoming dividends for Biohaven.

Q

When is Biohaven (NYSE:BHVN) reporting earnings?

A

Biohaven’s Q1 earnings are confirmed for Tuesday, May 9, 2023.

Q

Is Biohaven (BHVN) going to split?

A

There is no upcoming split for Biohaven.

Q

What sector and industry does Biohaven (BHVN) operate in?

A

Biohaven is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

Biohaven Stock (NYSE:BHVN), Quotes and News Summary

Biohaven Stock (NYSE: BHVN) stock price, news, charts, stock research, profile.

Loading...
Day Range17.950 - 18.67052 Wk Range7.100 - 152.560Open / Close18.460 / 18.090Float / Outstanding64.756M / 68.161M
Vol / Avg.687.568K / 1.087MMkt Cap1.230BP/E-50d Avg. Price16.230
Div / Yield (Forward)- / -%Payout Ratio-Total Float64.756MEPS-11.754
InvestorsObserver - Jan 24, 2023, 11:24AM
InvestorsObserver - Dec 13, 2022, 11:34AM
Seeking Alpha - Dec 7, 2022, 1:19PM
Seeking Alpha - Nov 25, 2022, 3:50AM
InvestorsObserver - Nov 21, 2022, 10:08AM
Seeking Alpha - Oct 31, 2022, 1:50AM
TipRanks - Oct 21, 2022, 11:42AM
InvestorsObserver - Oct 21, 2022, 10:14AM
Seeking Alpha - Sep 29, 2022, 8:32AM
Seeking Alpha - Sep 19, 2022, 6:52AM
Seeking Alpha - Aug 22, 2022, 7:29AM
Seeking Alpha - Aug 17, 2022, 6:40AM
Sector: Health Care.Industry: Biotechnology
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on discovering and developing therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, immunology, and disease-related biology, including rare disorders. Its neuroscience portfolio includes a broad pipeline of drug candidates modulating distinct nervous system targets, including Kv7, glutamate receptors, myostatin, and TRP channels. Its products target diseases such as migraine, depression, bipolar, and schizophrenia.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-09
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-24
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Biohaven (BHVN) stock?

A

You can purchase shares of Biohaven (NYSE: BHVN) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Biohaven (BHVN) stock?

A

The latest price target for Biohaven (NYSE: BHVN) was reported by SVB Leerink on Tuesday, January 24, 2023. The analyst firm set a price target for 24.00 expecting BHVN to rise to within 12 months (a possible 32.96% upside). 12 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Biohaven (BHVN)?

A

The stock price for Biohaven (NYSE: BHVN) is $18.05 last updated February 8, 2023 at 8:59 PM UTC.

Q

Does Biohaven (BHVN) pay a dividend?

A

There are no upcoming dividends for Biohaven.

Q

When is Biohaven (NYSE:BHVN) reporting earnings?

A

Biohaven’s Q1 earnings are confirmed for Tuesday, May 9, 2023.

Q

Is Biohaven (BHVN) going to split?

A

There is no upcoming split for Biohaven.

Q

What sector and industry does Biohaven (BHVN) operate in?

A

Biohaven is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

Biohaven Stock (NYSE:BHVN), Quotes and News Summary

Biohaven Stock (NYSE: BHVN) stock price, news, charts, stock research, profile.

Loading...
Day Range17.950 - 18.67052 Wk Range7.100 - 152.560Open / Close18.460 / 18.090Float / Outstanding64.756M / 68.161M
Vol / Avg.687.568K / 1.087MMkt Cap1.230BP/E-50d Avg. Price16.230
Div / Yield (Forward)- / -%Payout Ratio-Total Float64.756MEPS-11.754
InvestorsObserver - Jan 24, 2023, 11:24AM
InvestorsObserver - Dec 13, 2022, 11:34AM
Seeking Alpha - Dec 7, 2022, 1:19PM
Seeking Alpha - Nov 25, 2022, 3:50AM
InvestorsObserver - Nov 21, 2022, 10:08AM
Seeking Alpha - Oct 31, 2022, 1:50AM
TipRanks - Oct 21, 2022, 11:42AM
InvestorsObserver - Oct 21, 2022, 10:14AM
Seeking Alpha - Sep 29, 2022, 8:32AM
Seeking Alpha - Sep 19, 2022, 6:52AM
Seeking Alpha - Aug 22, 2022, 7:29AM
Seeking Alpha - Aug 17, 2022, 6:40AM
Sector: Health Care.Industry: Biotechnology
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on discovering and developing therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, immunology, and disease-related biology, including rare disorders. Its neuroscience portfolio includes a broad pipeline of drug candidates modulating distinct nervous system targets, including Kv7, glutamate receptors, myostatin, and TRP channels. Its products target diseases such as migraine, depression, bipolar, and schizophrenia.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-09
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-24
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Biohaven (BHVN) stock?

A

You can purchase shares of Biohaven (NYSE: BHVN) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Biohaven (BHVN) stock?

A

The latest price target for Biohaven (NYSE: BHVN) was reported by SVB Leerink on Tuesday, January 24, 2023. The analyst firm set a price target for 24.00 expecting BHVN to rise to within 12 months (a possible 32.96% upside). 12 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Biohaven (BHVN)?

A

The stock price for Biohaven (NYSE: BHVN) is $18.05 last updated February 8, 2023 at 8:59 PM UTC.

Q

Does Biohaven (BHVN) pay a dividend?

A

There are no upcoming dividends for Biohaven.

Q

When is Biohaven (NYSE:BHVN) reporting earnings?

A

Biohaven’s Q1 earnings are confirmed for Tuesday, May 9, 2023.

Q

Is Biohaven (BHVN) going to split?

A

There is no upcoming split for Biohaven.

Q

What sector and industry does Biohaven (BHVN) operate in?

A

Biohaven is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

Biohaven Stock (NYSE:BHVN), Quotes and News Summary

Biohaven Stock (NYSE: BHVN) stock price, news, charts, stock research, profile.

Loading...
Day Range17.950 - 18.67052 Wk Range7.100 - 152.560Open / Close18.460 / 18.090Float / Outstanding64.756M / 68.161M
Vol / Avg.687.568K / 1.087MMkt Cap1.230BP/E-50d Avg. Price16.230
Div / Yield (Forward)- / -%Payout Ratio-Total Float64.756MEPS-11.754
InvestorsObserver - Jan 24, 2023, 11:24AM
InvestorsObserver - Dec 13, 2022, 11:34AM
Seeking Alpha - Dec 7, 2022, 1:19PM
Seeking Alpha - Nov 25, 2022, 3:50AM
InvestorsObserver - Nov 21, 2022, 10:08AM
Seeking Alpha - Oct 31, 2022, 1:50AM
TipRanks - Oct 21, 2022, 11:42AM
InvestorsObserver - Oct 21, 2022, 10:14AM
Seeking Alpha - Sep 29, 2022, 8:32AM
Seeking Alpha - Sep 19, 2022, 6:52AM
Seeking Alpha - Aug 22, 2022, 7:29AM
Seeking Alpha - Aug 17, 2022, 6:40AM
Sector: Health Care.Industry: Biotechnology
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on discovering and developing therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, immunology, and disease-related biology, including rare disorders. Its neuroscience portfolio includes a broad pipeline of drug candidates modulating distinct nervous system targets, including Kv7, glutamate receptors, myostatin, and TRP channels. Its products target diseases such as migraine, depression, bipolar, and schizophrenia.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-09
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-24
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Biohaven (BHVN) stock?

A

You can purchase shares of Biohaven (NYSE: BHVN) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Biohaven (BHVN) stock?

A

The latest price target for Biohaven (NYSE: BHVN) was reported by SVB Leerink on Tuesday, January 24, 2023. The analyst firm set a price target for 24.00 expecting BHVN to rise to within 12 months (a possible 32.96% upside). 12 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Biohaven (BHVN)?

A

The stock price for Biohaven (NYSE: BHVN) is $18.05 last updated February 8, 2023 at 8:59 PM UTC.

Q

Does Biohaven (BHVN) pay a dividend?

A

There are no upcoming dividends for Biohaven.

Q

When is Biohaven (NYSE:BHVN) reporting earnings?

A

Biohaven’s Q1 earnings are confirmed for Tuesday, May 9, 2023.

Q

Is Biohaven (BHVN) going to split?

A

There is no upcoming split for Biohaven.

Q

What sector and industry does Biohaven (BHVN) operate in?

A

Biohaven is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

Biohaven Stock (NYSE:BHVN), Quotes and News Summary

Biohaven Stock (NYSE: BHVN) stock price, news, charts, stock research, profile.

Loading...
Day Range17.950 - 18.67052 Wk Range7.100 - 152.560Open / Close18.460 / 18.090Float / Outstanding64.756M / 68.161M
Vol / Avg.687.568K / 1.087MMkt Cap1.230BP/E-50d Avg. Price16.230
Div / Yield (Forward)- / -%Payout Ratio-Total Float64.756MEPS-11.754
InvestorsObserver - Jan 24, 2023, 11:24AM
InvestorsObserver - Dec 13, 2022, 11:34AM
Seeking Alpha - Dec 7, 2022, 1:19PM
Seeking Alpha - Nov 25, 2022, 3:50AM
InvestorsObserver - Nov 21, 2022, 10:08AM
Seeking Alpha - Oct 31, 2022, 1:50AM
TipRanks - Oct 21, 2022, 11:42AM
InvestorsObserver - Oct 21, 2022, 10:14AM
Seeking Alpha - Sep 29, 2022, 8:32AM
Seeking Alpha - Sep 19, 2022, 6:52AM
Seeking Alpha - Aug 22, 2022, 7:29AM
Seeking Alpha - Aug 17, 2022, 6:40AM
Sector: Health Care.Industry: Biotechnology
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on discovering and developing therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, immunology, and disease-related biology, including rare disorders. Its neuroscience portfolio includes a broad pipeline of drug candidates modulating distinct nervous system targets, including Kv7, glutamate receptors, myostatin, and TRP channels. Its products target diseases such as migraine, depression, bipolar, and schizophrenia.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-09
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-24
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Biohaven (BHVN) stock?

A

You can purchase shares of Biohaven (NYSE: BHVN) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Biohaven (BHVN) stock?

A

The latest price target for Biohaven (NYSE: BHVN) was reported by SVB Leerink on Tuesday, January 24, 2023. The analyst firm set a price target for 24.00 expecting BHVN to rise to within 12 months (a possible 32.96% upside). 12 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Biohaven (BHVN)?

A

The stock price for Biohaven (NYSE: BHVN) is $18.05 last updated February 8, 2023 at 8:59 PM UTC.

Q

Does Biohaven (BHVN) pay a dividend?

A

There are no upcoming dividends for Biohaven.

Q

When is Biohaven (NYSE:BHVN) reporting earnings?

A

Biohaven’s Q1 earnings are confirmed for Tuesday, May 9, 2023.

Q

Is Biohaven (BHVN) going to split?

A

There is no upcoming split for Biohaven.

Q

What sector and industry does Biohaven (BHVN) operate in?

A

Biohaven is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

Biohaven Stock (NYSE:BHVN), Quotes and News Summary

Biohaven Stock (NYSE: BHVN) stock price, news, charts, stock research, profile.

Loading...
Day Range17.950 - 18.67052 Wk Range7.100 - 152.560Open / Close18.460 / 18.090Float / Outstanding64.756M / 68.161M
Vol / Avg.687.568K / 1.087MMkt Cap1.230BP/E-50d Avg. Price16.230
Div / Yield (Forward)- / -%Payout Ratio-Total Float64.756MEPS-11.754
InvestorsObserver - Jan 24, 2023, 11:24AM
InvestorsObserver - Dec 13, 2022, 11:34AM
Seeking Alpha - Dec 7, 2022, 1:19PM
Seeking Alpha - Nov 25, 2022, 3:50AM
InvestorsObserver - Nov 21, 2022, 10:08AM
Seeking Alpha - Oct 31, 2022, 1:50AM
TipRanks - Oct 21, 2022, 11:42AM
InvestorsObserver - Oct 21, 2022, 10:14AM
Seeking Alpha - Sep 29, 2022, 8:32AM
Seeking Alpha - Sep 19, 2022, 6:52AM
Seeking Alpha - Aug 22, 2022, 7:29AM
Seeking Alpha - Aug 17, 2022, 6:40AM
Sector: Health Care.Industry: Biotechnology
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on discovering and developing therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, immunology, and disease-related biology, including rare disorders. Its neuroscience portfolio includes a broad pipeline of drug candidates modulating distinct nervous system targets, including Kv7, glutamate receptors, myostatin, and TRP channels. Its products target diseases such as migraine, depression, bipolar, and schizophrenia.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-09
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-24
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Biohaven (BHVN) stock?

A

You can purchase shares of Biohaven (NYSE: BHVN) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Biohaven (BHVN) stock?

A

The latest price target for Biohaven (NYSE: BHVN) was reported by SVB Leerink on Tuesday, January 24, 2023. The analyst firm set a price target for 24.00 expecting BHVN to rise to within 12 months (a possible 32.96% upside). 12 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Biohaven (BHVN)?

A

The stock price for Biohaven (NYSE: BHVN) is $18.05 last updated February 8, 2023 at 8:59 PM UTC.

Q

Does Biohaven (BHVN) pay a dividend?

A

There are no upcoming dividends for Biohaven.

Q

When is Biohaven (NYSE:BHVN) reporting earnings?

A

Biohaven’s Q1 earnings are confirmed for Tuesday, May 9, 2023.

Q

Is Biohaven (BHVN) going to split?

A

There is no upcoming split for Biohaven.

Q

What sector and industry does Biohaven (BHVN) operate in?

A

Biohaven is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.